A meta-analysis of safety and efficacy of datopotamab deruxtecan and sacituzumab govitecan for second line treatment of metastatic non-small cell lung cancer (NSCLC).
Year: 2025
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Journal of Clinical Oncology
Authors: Omar Shukri Yaghi, Matthew Seebald, Laura Abate, Esin Christine Namoglu, Ruxandra Nicolae, Javier Vera, Evan Cain, Brendan James Lohmar, Shawn Reginauld, Sora Ely, Prashanth Ashok Kumar
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410805336